NBO Pharma Inc
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.nbopharma.comRevenue
<$5 MillionIndustry
About NBO Pharma Inc
NBO Pharma Inc Org Chart
Is NBO Pharma Inc your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NBO Pharma Inc launches new products
Funding: Get notified immidiatlly once NBO Pharma Inc has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if NBO Pharma Inc has recently received funding, and reach out quickly before it becomes old news!
NBO Pharma Inc, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if NBO Pharma Inc had a recent Job posting/layoffs
Earning: See what the market has to say on NBO Pharma Inc recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at NBO Pharma Inc
Check out if NBO Pharma Inc is spiking on competitors!
Recommended Actions
Find VP level buyers at NBO Pharma Inc
Find 3 more new buyers
Company Profile Activity
Activity Insights
NBO Pharma Inc is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NBO Pharma Inc is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NBO Pharma Inc.
NBO Pharma Inc financials insights
Gather financial insights about NBO Pharma Inc, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Stock/Share Issuance
$7.6M
Top Business Services Companies
Frequently Asked Questions Regarding NBO Pharma Inc
NBO (acronym for Nasal Bioavailability of Octreotide) Pharma Inc. was incorporated in 2021 to develop a drug for the treatment of Idiopathic Intracranial Hypertension [IIH] for which no drugs are approved. We are re-purposing an existing orphan drug octreotide acetate with an Intranasal [IN] formulation. IN octreotide is undergoing clinical trials... Read More